nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Adaptogenic flower buds exert cancer preventive effects by enhancing the SCFA-producers, strengthening the epithelial tight junction complex and immune responses
|
Xia, Wenrui |
|
|
159 |
C |
p. |
artikel |
2 |
Age, sex, and specific gene mutations affect the effects of immune checkpoint inhibitors in colorectal cancer
|
Lin, Anqi |
|
|
159 |
C |
p. |
artikel |
3 |
AGK2 ameliorates mast cell-mediated allergic airway inflammation and fibrosis by inhibiting FcεRI/TGF-β signaling pathway
|
Kim, Yeon-Yong |
|
|
159 |
C |
p. |
artikel |
4 |
Angiotensin receptor blockers for the treatment of COVID-19 and its comorbidities
|
Saavedra, Juan M. |
|
|
159 |
C |
p. |
artikel |
5 |
An innovative method for screening and evaluating the degree of diabetic retinopathy and drug treatment based on artificial intelligence algorithms
|
Xie, Qiwei |
|
|
159 |
C |
p. |
artikel |
6 |
Antiproteinuric effect of DPP-IV inhibitors in diabetic and non-diabetic kidney diseases
|
Nicotera, Ramona |
|
|
159 |
C |
p. |
artikel |
7 |
Arctiin abrogates osteoclastogenesis and bone resorption via suppressing RANKL-induced ROS and NFATc1 activation
|
Chen, Delong |
|
|
159 |
C |
p. |
artikel |
8 |
Artemisinin protects motoneurons against axotomy-induced apoptosis through activation of the PKA-Akt signaling pathway and promotes neural stem/progenitor cells differentiation into NeuN+ neurons
|
Liu, Linlin |
|
|
159 |
C |
p. |
artikel |
9 |
Artificial intelligence and network pharmacology based investigation of pharmacological mechanism and substance basis of Xiaokewan in treating diabetes
|
Zhu, Chunyan |
|
|
159 |
C |
p. |
artikel |
10 |
A specific gut microbiota and metabolomic profiles shifts related to antidiabetic action: The similar and complementary antidiabetic properties of type 3 resistant starch from Canna edulis and metformin
|
Zhang, Chi |
|
|
159 |
C |
p. |
artikel |
11 |
Beyond the limitation of targeted therapy: Improve the application of targeted drugs combining genomic data with machine learning
|
Miao, Rui |
|
|
159 |
C |
p. |
artikel |
12 |
Biochemical indicators of coronavirus disease 2019 exacerbation and the clinical implications
|
An, Peng-jiao |
|
|
159 |
C |
p. |
artikel |
13 |
Blame the signaling: Role of cAMP for the resolution of inflammation
|
Tavares, Luciana P. |
|
|
159 |
C |
p. |
artikel |
14 |
Bletilla striata oligosaccharides improve metabolic syndrome through modulation of gut microbiota and intestinal metabolites in high fat diet-fed mice
|
Hu, Baifei |
|
|
159 |
C |
p. |
artikel |
15 |
Chelidonine selectively inhibits the growth of gefitinib-resistant non-small cell lung cancer cells through the EGFR-AMPK pathway
|
Xie, Ya-Jia |
|
|
159 |
C |
p. |
artikel |
16 |
Chlorquinaldol targets the β-catenin and T-cell factor 4 complex and exerts anti-colorectal cancer activity
|
Wang, Ling |
|
|
159 |
C |
p. |
artikel |
17 |
Clinical approach to the inflammatory etiology of cardiovascular diseases
|
Ruscica, Massimiliano |
|
|
159 |
C |
p. |
artikel |
18 |
Clinical efficacy and predictors of response to dulaglutide in type-2 diabetes
|
Berra, C.C. |
|
|
159 |
C |
p. |
artikel |
19 |
Clinical impact of pre-admission antithrombotic therapy in hospitalized patients with COVID-19: A multicenter observational study
|
Russo, Vincenzo |
|
|
159 |
C |
p. |
artikel |
20 |
Controlling leukocyte trafficking in IBD
|
Veny, Marisol |
|
|
159 |
C |
p. |
artikel |
21 |
Corrigendum to “S1PR2 inhibitors potently reverse 5-FU resistance by downregulating DPD expression in colorectal cancer” [Pharmacol Res. 155 (2020) 104717]
|
Zhang, Yu-Hang |
|
|
159 |
C |
p. |
artikel |
22 |
Corrigendum to “The role of the LTB4-BLT1 axis in health and disease” [Pharmacol. Res. 158 (2020) 104857]
|
He, Rui |
|
|
159 |
C |
p. |
artikel |
23 |
COVID-19 and Kawasaki disease in children
|
Xu, Suowen |
|
|
159 |
C |
p. |
artikel |
24 |
Curcumin: an inflammasome silencer
|
Hasanzadeh, Shima |
|
|
159 |
C |
p. |
artikel |
25 |
Cutaneous endocannabinoid system: Does it have a role on skin wound healing bearing fibrosis?
|
Correia-Sá, Inês |
|
|
159 |
C |
p. |
artikel |
26 |
CXCR4 antagonist AMD3100 (plerixafor): From an impurity to a therapeutic agent
|
Wang, Jingzhe |
|
|
159 |
C |
p. |
artikel |
27 |
Databases for facilitating mechanistic investigations of traditional Chinese medicines against COVID-19
|
Jiang, Sida |
|
|
159 |
C |
p. |
artikel |
28 |
Delivery routes for faecal microbiota transplants: Available, anticipated and aspired
|
Gulati, Monica |
|
|
159 |
C |
p. |
artikel |
29 |
Discovery of the FDA-approved drugs bexarotene, cetilistat, diiodohydroxyquinoline, and abiraterone as potential COVID-19 treatments with a robust two-tier screening system
|
Yuan, Shuofeng |
|
|
159 |
C |
p. |
artikel |
30 |
East meets West in COVID-19 therapeutics
|
Wang, Shanshan |
|
|
159 |
C |
p. |
artikel |
31 |
Editorial Board
|
|
|
|
159 |
C |
p. |
artikel |
32 |
Effect of Carbonic Anhydrase IX inhibitors on human endothelial cell survival
|
Genah, Shirley |
|
|
159 |
C |
p. |
artikel |
33 |
Efficacy and safety of HIF prolyl-hydroxylase inhibitor vs epoetin and darbepoetin for anemia in chronic kidney disease patients not undergoing dialysis: A network meta-analysis
|
Zheng, Qiyan |
|
|
159 |
C |
p. |
artikel |
34 |
Ephrin-Eph signaling usage by a variety of viruses
|
de Boer, Esther C.W. |
|
|
159 |
C |
p. |
artikel |
35 |
Epoxyeicosatrienoic acids: Emerging therapeutic agents for central post-stroke pain
|
Wan, Li |
|
|
159 |
C |
p. |
artikel |
36 |
Erinacine A and related cyathane diterpenoids: Molecular diversity and mechanisms underlying their neuroprotection and anticancer activities
|
Bailly, Christian |
|
|
159 |
C |
p. |
artikel |
37 |
Evodiamine has therapeutic efficacy in ulcerative colitis by increasing Lactobacillus acidophilus levels and acetate production
|
Wang, Meng-Xia |
|
|
159 |
C |
p. |
artikel |
38 |
Exploring the mechanism of TCM formulae in the treatment of different types of coronary heart disease by network pharmacology and machining learning
|
Yang, Jian |
|
|
159 |
C |
p. |
artikel |
39 |
Fecal bacteria can predict the efficacy of rifaximin in patients with diarrhea-predominant irritable bowel syndrome
|
Li, Ying |
|
|
159 |
C |
p. |
artikel |
40 |
First evidence of aryl hydrocarbon receptor as a druggable target in hypertension induced by chronic intermittent hypoxia
|
Coelho, Nuno R. |
|
|
159 |
C |
p. |
artikel |
41 |
Gap-134, a Connexin43 activator, prevents age-related development of ventricular fibrosis in Scn5a+/ − mice
|
Patin, Justine |
|
|
159 |
C |
p. |
artikel |
42 |
Genetics and epigenetics of IBD
|
Annese, Vito |
|
|
159 |
C |
p. |
artikel |
43 |
Global research on artemisinin and its derivatives: Perspectives from patents
|
Liu, Kunmeng |
|
|
159 |
C |
p. |
artikel |
44 |
Green tea improves the metabolism of peripheral tissues in β3-adrenergic receptor-knockout mice
|
Sousa-Filho, Celso Pereira Batista |
|
|
159 |
C |
p. |
artikel |
45 |
HBV induced hepatocellular carcinoma and related potential immunotherapy
|
Jia, Liyang |
|
|
159 |
C |
p. |
artikel |
46 |
Hypoxia-inducible factor-1α: A promising therapeutic target for vasculopathy in diabetic retinopathy
|
Li, Hui-Yao |
|
|
159 |
C |
p. |
artikel |
47 |
Indoleamine 2,3-dioxygenase in melanoma progression and BRAF inhibitor resistance
|
Sandri, Silvana |
|
|
159 |
C |
p. |
artikel |
48 |
Inflammatory bowel diseases, the hygiene hypothesis and the other side of the microbiota: Parasites and fungi
|
Panelli, Simona |
|
|
159 |
C |
p. |
artikel |
49 |
Innovative health risk assessment of heavy metals in Chinese herbal medicines based on extensive data
|
Zuo, Tian-Tian |
|
|
159 |
C |
p. |
artikel |
50 |
Interactions of antithrombotic herbal medicines with Western cardiovascular drugs
|
Zuo, Hua-Li |
|
|
159 |
C |
p. |
artikel |
51 |
Intermedin alleviates pathological cardiac remodeling by upregulating klotho
|
Zhang, Lin-Shuang |
|
|
159 |
C |
p. |
artikel |
52 |
LSD1 deletion represses gastric cancer migration by upregulating a novel miR-142-5p target protein CD9
|
Zhao, Li-Juan |
|
|
159 |
C |
p. |
artikel |
53 |
Lycopene in protection against obesity and diabetes: A mechanistic review
|
Zhu, Ruyuan |
|
|
159 |
C |
p. |
artikel |
54 |
Lymecycline reverses acquired EGFR-TKI resistance in non–small-cell lung cancer by targeting GRB2
|
Chen, Yang |
|
|
159 |
C |
p. |
artikel |
55 |
Mechanopharmacology of Rho-kinase antagonism in airway smooth muscle and potential new therapy for asthma
|
Wang, Lu |
|
|
159 |
C |
p. |
artikel |
56 |
Microbiota and cardiovascular disease risk: A scoping review
|
Scarmozzino, Federico |
|
|
159 |
C |
p. |
artikel |
57 |
Microbiota-derived butyrate regulates intestinal inflammation: Focus on inflammatory bowel disease
|
Couto, Mafalda R. |
|
|
159 |
C |
p. |
artikel |
58 |
Molecular mechanisms of hepatic insulin resistance in nonalcoholic fatty liver disease and potential treatment strategies
|
Zhang, Chang-hua |
|
|
159 |
C |
p. |
artikel |
59 |
Myo–inositol and d-chiro–inositol oral supplementation ameliorate cardiac dysfunction and remodeling in a mouse model of diet-induced obesity
|
L’Abbate, Serena |
|
|
159 |
C |
p. |
artikel |
60 |
Network pharmacological approach for elucidating the mechanisms of traditional Chinese medicine in treating COVID-19 patients
|
Pan, Hu-Dan |
|
|
159 |
C |
p. |
artikel |
61 |
Nose to brain drug delivery - A promising strategy for active components from herbal medicine for treating cerebral ischemia reperfusion
|
Long, Yu |
|
|
159 |
C |
p. |
artikel |
62 |
Nuclear Factor Kappa B in Autism Spectrum Disorder: A Systematic Review
|
Liao, Xiaoli |
|
|
159 |
C |
p. |
artikel |
63 |
Opioid receptors beyond pain control: The role in cancer pathology and the debated importance of their pharmacological modulation
|
Carli, Marco |
|
|
159 |
C |
p. |
artikel |
64 |
Opioid system influences gut-brain axis: Dysbiosis and related alterations
|
Rueda-Ruzafa, Lola |
|
|
159 |
C |
p. |
artikel |
65 |
Oroxylin A suppresses ACTN1 expression to inactivate cancer-associated fibroblasts and restrain breast cancer metastasis
|
Cao, Yue |
|
|
159 |
C |
p. |
artikel |
66 |
Pharmacological data of cannabidiol- and cannabigerol-type phytocannabinoids acting on cannabinoid CB1, CB2 and CB1/CB2 heteromer receptors
|
Navarro, Gemma |
|
|
159 |
C |
p. |
artikel |
67 |
Promising targets based on pattern recognition receptors for cancer immunotherapy
|
Bai, Ling |
|
|
159 |
C |
p. |
artikel |
68 |
Protein tyrosine phosphatase 1B inhibition as a potential therapeutic target for chronic wounds in diabetes
|
Figueiredo, Ana |
|
|
159 |
C |
p. |
artikel |
69 |
Proteotoxicity and mitochondrial dynamics in aging diabetic brain
|
Fernandes, Valencia |
|
|
159 |
C |
p. |
artikel |
70 |
Rimeporide as a first- in-class NHE-1 inhibitor: Results of a phase Ib trial in young patients with Duchenne Muscular Dystrophy
|
Previtali, Stefano C. |
|
|
159 |
C |
p. |
artikel |
71 |
Role of 5-HT receptors in neuropathic pain: potential therapeutic implications
|
Liu, Qian Qian |
|
|
159 |
C |
p. |
artikel |
72 |
Role of nitroxyl (HNO) in cardiovascular system: From biochemistry to pharmacology
|
Sun, Hai-Jian |
|
|
159 |
C |
p. |
artikel |
73 |
Rottlerin acts as a therapeutic in primary open-angle glaucoma by targeting the trabecular meshwork via activation of Rap1 signaling
|
Zhu, Jingyi |
|
|
159 |
C |
p. |
artikel |
74 |
S-allylmercaptocysteine inhibits mucin overexpression and inflammation via MAPKs and PI3K-Akt signaling pathways in acute respiratory distress syndrome
|
An, Lulu |
|
|
159 |
C |
p. |
artikel |
75 |
Searching for novel hydrogen sulfide donors: The vascular effects of two thiourea derivatives
|
Citi, Valentina |
|
|
159 |
C |
p. |
artikel |
76 |
Sestrin2 as a potential therapeutic target for cardiovascular diseases
|
Gao, Anbo |
|
|
159 |
C |
p. |
artikel |
77 |
Sirt3 is a novel target to treat sepsis induced myocardial dysfunction by acetylated modulation of critical enzymes within cardiac tricarboxylic acid cycle
|
Xu, Yinchuan |
|
|
159 |
C |
p. |
artikel |
78 |
Spermidine as a target for cancer therapy
|
Fan, Jingjing |
|
|
159 |
C |
p. |
artikel |
79 |
Statins and other drugs: Facing COVID-19 as a vascular disease
|
Sanchis-Gomar, Fabian |
|
|
159 |
C |
p. |
artikel |
80 |
SVCT2-Dependent plasma and mitochondrial membrane transport of ascorbic acid in differentiating myoblasts
|
Fiorani, Mara |
|
|
159 |
C |
p. |
artikel |
81 |
Targeting inflammation and cytokine storm in COVID-19
|
Huang, Qianwen |
|
|
159 |
C |
p. |
artikel |
82 |
Targeting metabolic syndrome with phytochemicals: Focus on the role of molecular chaperones and hormesis in drug discovery
|
Lakshmi, P.K. |
|
|
159 |
C |
p. |
artikel |
83 |
Targeting T cells in inflammatory bowel disease
|
Giuffrida, Paolo |
|
|
159 |
C |
p. |
artikel |
84 |
Targeting the vascular endothelial growth factor receptor-1 by the monoclonal antibody D16F7 to increase the activity of immune checkpoint inhibitors against cutaneous melanoma
|
Lacal, Pedro Miguel |
|
|
159 |
C |
p. |
artikel |
85 |
Ternary complex factor regulates pancreatic islet size and blood glucose homeostasis in transgenic mice
|
Lesch, Andrea |
|
|
159 |
C |
p. |
artikel |
86 |
The ameliorating effects of anthocyanins on the cross-linked signaling pathways of cancer dysregulated metabolism
|
Fakhri, Sajad |
|
|
159 |
C |
p. |
artikel |
87 |
The Application of Ferroptosis in Diseases
|
Qiu, Yangmin |
|
|
159 |
C |
p. |
artikel |
88 |
The database-based strategy may overstate the potential effects of traditional Chinese medicine against COVID-19
|
Huang, Yu-Xi |
|
|
159 |
C |
p. |
artikel |
89 |
The effect of voglibose on metabolic profiles in patients with type 2 diabetes mellitus: A systematic review and meta-analysis of clinical trials
|
Nowrouzi-Sohrabi, Peyman |
|
|
159 |
C |
p. |
artikel |
90 |
The effects of ginsenosides on platelet aggregation and vascular intima in the treatment of cardiovascular diseases: From molecular mechanisms to clinical applications
|
Luo, Bang-Yue |
|
|
159 |
C |
p. |
artikel |
91 |
The effects of metformin administration on liver enzymes and body composition in non-diabetic patients with non-alcoholic fatty liver disease and/or non-alcoholic steatohepatitis: An up-to date systematic review and meta-analysis of randomized controlled trials
|
Jalali, Mohammad |
|
|
159 |
C |
p. |
artikel |
92 |
The efficacy and safety of ipriflavone in postmenopausal women with osteopenia or osteoporosis: A systematic review and meta-analysis
|
Hu, Qinsheng |
|
|
159 |
C |
p. |
artikel |
93 |
The flavonoid agathisflavone modulates the microglial neuroinflammatory response and enhances remyelination
|
de Almeida, Monique Marylin Alves |
|
|
159 |
C |
p. |
artikel |
94 |
The gut microbes, Enterococcus and Escherichia-Shigella, affect the responses of heart valve replacement patients to the anticoagulant warfarin
|
Wang, Lin |
|
|
159 |
C |
p. |
artikel |
95 |
The need for physiological phenotyping to develop new drugs for airways disease
|
Chapman, David G |
|
|
159 |
C |
p. |
artikel |
96 |
Therapeutic potential of genipin in various acute liver injury, fulminant hepatitis, NAFLD and other non-cancer liver diseases: More friend than foe
|
Fan, Xiaofei |
|
|
159 |
C |
p. |
artikel |
97 |
Therapeutic potential of pharmacological agents targeting TRP channels in CNS disorders
|
Thapak, Pavan |
|
|
159 |
C |
p. |
artikel |
98 |
The risk of hepatocellular carcinoma and aspirin use
|
Liao, Kuan-Fu |
|
|
159 |
C |
p. |
artikel |
99 |
Tissue-resident memory CD8+ T cells in cancer immunology and immunotherapy
|
Wang, Ting |
|
|
159 |
C |
p. |
artikel |
100 |
Treatment of dilated cardiomyopathy in a mouse model of Friedreich’s ataxia using N-acetylcysteine and identification of alterations in microRNA expression that could be involved in its pathogenesis
|
Chiang, S. |
|
|
159 |
C |
p. |
artikel |
101 |
Tumor-derived extracellular vesicles: Regulators of tumor microenvironment and the enlightenment in tumor therapy
|
Chen, Jiming |
|
|
159 |
C |
p. |
artikel |
102 |
Tumor microenvironment-related dendritic cell deficiency: a target to enhance tumor immunotherapy
|
Zhu, Shan |
|
|
159 |
C |
p. |
artikel |
103 |
What’s new in IBD therapy: An “omics network” approach
|
Fiocchi, Claudio |
|
|
159 |
C |
p. |
artikel |
104 |
Would ACEIs/ARBs be beneficial for COVID-19 patients without hypertension?
|
Huang, Ying |
|
|
159 |
C |
p. |
artikel |
105 |
Yes-associated protein and transcriptional coactivator with PDZ-binding motif as new targets in cardiovascular diseases
|
Yu, Yue |
|
|
159 |
C |
p. |
artikel |
106 |
ZLY032, the first-in-class dual FFA1/PPARδ agonist, improves glucolipid metabolism and alleviates hepatic fibrosis
|
Li, Zheng |
|
|
159 |
C |
p. |
artikel |